Frontiers in Psychiatry (Jul 2021)
Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms
- Lydia Fortea,
- Lydia Fortea,
- Lydia Fortea,
- Aleix Solanes,
- Aleix Solanes,
- Edith Pomarol-Clotet,
- Edith Pomarol-Clotet,
- Maria Angeles Garcia-Leon,
- Adriana Fortea,
- Adriana Fortea,
- Carla Torrent,
- Carla Torrent,
- Carla Torrent,
- Cristina Varo,
- Cristina Varo,
- Cristina Varo,
- Cristina Varo,
- C. Mar Bonnin,
- C. Mar Bonnin,
- C. Mar Bonnin,
- C. Mar Bonnin,
- Laura Montejo,
- Laura Montejo,
- Laura Montejo,
- Laura Montejo,
- Jordi Alonso,
- Jordi Alonso,
- Jordi Alonso,
- Susana Carmona,
- Susana Carmona,
- Susana Carmona,
- Pau Soldevila-Matías,
- Irene Alustiza,
- Irene Alustiza,
- Daniel Arbós,
- Diego Hidalgo-Mazzei,
- Diego Hidalgo-Mazzei,
- Diego Hidalgo-Mazzei,
- Diego Hidalgo-Mazzei,
- Iria Grande,
- Iria Grande,
- Iria Grande,
- Iria Grande,
- Eduard Vieta,
- Eduard Vieta,
- Eduard Vieta,
- Eduard Vieta,
- Miquel Àngel Fullana,
- Miquel Àngel Fullana,
- Miquel Àngel Fullana,
- Joaquim Radua,
- Joaquim Radua,
- Joaquim Radua,
- Joaquim Radua
Affiliations
- Lydia Fortea
- Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Lydia Fortea
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Lydia Fortea
- Department of Medicine, University of Barcelona, Barcelona, Spain
- Aleix Solanes
- Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Aleix Solanes
- Department of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, Spain
- Edith Pomarol-Clotet
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Edith Pomarol-Clotet
- FIDMAG Research Foundation, Barcelona, Spain
- Maria Angeles Garcia-Leon
- FIDMAG Research Foundation, Barcelona, Spain
- Adriana Fortea
- Multimodal Neuroimaging in High Risk and Early Psychosis, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Adriana Fortea
- Department of Child and Adolescent Psychiatry, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain
- Carla Torrent
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Carla Torrent
- Adult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain
- Carla Torrent
- Bipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Cristina Varo
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Cristina Varo
- Department of Medicine, University of Barcelona, Barcelona, Spain
- Cristina Varo
- Adult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain
- Cristina Varo
- Bipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- C. Mar Bonnin
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- C. Mar Bonnin
- Department of Medicine, University of Barcelona, Barcelona, Spain
- C. Mar Bonnin
- Adult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain
- C. Mar Bonnin
- Bipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Laura Montejo
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Laura Montejo
- Department of Medicine, University of Barcelona, Barcelona, Spain
- Laura Montejo
- Adult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain
- Laura Montejo
- Bipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Jordi Alonso
- 0Health Services Research Unit, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain
- Jordi Alonso
- 1Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain
- Jordi Alonso
- 2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
- Susana Carmona
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Susana Carmona
- 3Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
- Susana Carmona
- 4Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Getafe, Spain
- Pau Soldevila-Matías
- 5Department of Basic Psychology, Faculty of Psychology, University of Valencia, Valencia, Spain
- Irene Alustiza
- 6Department of Psychiatry and Clinical Psychology, Clínica Universidad de Navarra, Pamplona, Spain
- Irene Alustiza
- 7Instituto de Investigación Sanitaria de Navarra (IDISNA), Navarra, Spain
- Daniel Arbós
- 8Communication Office, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Diego Hidalgo-Mazzei
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Diego Hidalgo-Mazzei
- Department of Medicine, University of Barcelona, Barcelona, Spain
- Diego Hidalgo-Mazzei
- Adult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain
- Diego Hidalgo-Mazzei
- Bipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Iria Grande
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Iria Grande
- Department of Medicine, University of Barcelona, Barcelona, Spain
- Iria Grande
- Adult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain
- Iria Grande
- Bipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Eduard Vieta
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Eduard Vieta
- Department of Medicine, University of Barcelona, Barcelona, Spain
- Eduard Vieta
- Adult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain
- Eduard Vieta
- Bipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Miquel Àngel Fullana
- Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Miquel Àngel Fullana
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Miquel Àngel Fullana
- Adult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain
- Joaquim Radua
- Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Joaquim Radua
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain
- Joaquim Radua
- 9Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
- Joaquim Radua
- 0Centre for Psychiatric Research and Education, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- DOI
- https://doi.org/10.3389/fpsyt.2021.642763
- Journal volume & issue
-
Vol. 12
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic and lockdown might increase anxiety and depressive symptoms in most individuals. Health bodies recommend several coping behaviors to protect against such symptoms, but evidence on the relationship between these behaviors and symptoms mostly comes from cross-sectional studies in convenience samples. We will conduct a prospective longitudinal study of the associations between coping behaviors and subsequent anxiety and depressive symptoms during the COVID-19 pandemic in a representative sample of the Spanish general adult population.Methods: We will recruit 1,000 adult participants from all autonomous communities of Spain and with sex, age, and urbanicity distributions similar to those of their populations and assess anxiety and depressive symptoms and coping behaviors using fortnightly questionnaires and real-time methods (ecological momentary assessments) for 1 year. The fortnightly questionnaires will inquire about anxiety and depressive symptoms [General Anxiety Disorder-7 (GAD-7) and Patient Health Questionnaire-9 (PHQ-9)] and the frequency of 10 potential coping behaviors (e.g., follow a routine) during the past 2 weeks. In addition, we will collect several variables that could confound or moderate these associations. These will include subjective well-being [International Positive and Negative Affect Schedule Short Form (I-PANAS-SF) and Satisfaction with Life Scale (SWLS)], obsessive-compulsive symptoms [Obsessive Compulsive Inventory-Revised (OCI-R)], personality and emotional intelligence [International Personality Item Pool (IPIP) and Trait Emotional Intelligence Questionnaire Short Form (TEIQue-SF)], sociodemographic factors (e.g., work status, housing-built environment), and COVID-19 pandemic-related variables (e.g., hospitalizations or limitations in social gatherings). Finally, to analyze the primary relationship between coping behaviors and subsequent anxiety and depressive symptoms, we will use autoregressive moving average (ARMA) models.Discussion: Based on the study results, we will develop evidence-based, clear, and specific recommendations on coping behaviors during the COVID-19 pandemic and lockdown. Such suggestions might eventually help health bodies or individuals to manage current or future pandemics.
Keywords